Myeongmun Pharmaceutical ranked among the top searched stocks for 2 days within the past month.


As of 1:30 PM on the 22nd, Myeongmun Pharmaceutical is trading at 10,150 KRW, up 7.75% from the previous day. This marks a 64.24% increase compared to November 25. Myeongmun Pharmaceutical is known as a comprehensive pharmaceutical company focusing on prescription drugs.

Today, foreigners have sold a net 13,000 shares of Myeongmun Pharmaceutical, and institutions have sold a net 16,000 shares, according to provisional data. Over the past 5 days, individual investors have bought a net 215,161 shares, while foreigners and institutions have sold a net 111,356 shares and 27,328 shares, respectively.


On December 18, Myeongmun Pharmaceutical became a market topic with the announcement of the release of 'Hoistar tablets with the same ingredient as the oral COVID-19 treatment'...





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing